Autopsy report · NCT02021084

The Effect of Probiotics on Response to Therapy and on Adverse Effect in Patients Treated With Colchicine for Familial Mediterranean Fever.

“no patient enroled”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Rambam Health Care Campus

Sponsor type

University, hospital or other

Conditions

Familial Mediterranean Fever (FMF )

Interventions

probiotic; Placebo

Participants

0

Trials that died the same way

• Survey Study and Records Review of Treatment Outcomes in Freeman-Sheldon Syndrome
  “Insufficient patient enrolment” (84% match in meaning)
• Hepatitis C in Prison: Study of Screening and Rapid Treatment (HEPAPRIS)
  “No patient eligible” (82% match in meaning)
• The Efficacy and Safety of Alemtuzumab in Auotoimmune Cytopenias
  “no eligible patient” (78% match in meaning)
• A2R and Ectonucleotidases Expression in Lung Cancer Circulating Tumor Cells
  “no patients enrolled” (76% match in meaning)
• Treatment of Exercise-induced Laryngomalacia in Elite Athletes
  “No patients willing to join” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.